Ipamorelin
Ipamorelin
Also known as: Ipamorelin Acetate, IPA, NNC 26-0161
Overview
Key Facts
Primary Goal: A highly selective growth hormone secretagogue that stimulates GH release from the pituitary via the ghrelin receptor (GHS-R1a)
A highly selective growth hormone secretagogue that stimulates GH release from the pituitary via the ghrelin receptor (GHS-R1a). Ipamorelin is particularly relevant to sleep because the largest natural GH pulse occurs during deep slow-wave sleep. By amplifying this pulse when administered before bedtime, Ipamorelin enhances sleep quality, promotes overnight recovery, and deepens restorative sleep phases — all without significantly affecting cortisol or prolactin levels. Half-Life ~2 hours Typical Dose 100–300 mcg Frequency Once daily, 30-60 minutes before bedtime Cycle Length 8-12 weeks on, 4 weeks off
Dosing Information
Half-Life
~2 hours
Typical Dose
100–300 mcg
Frequency
Once daily, 30-60 minutes before bedtime
Cycle Length
8-12 weeks on, 4 weeks off
Administration Routes:
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
Ipamorelin was developed by Novo Nordisk and has been studied in multiple Phase 1 and Phase 2 trials. A key study demonstrated dose-dependent GH release with remarkable selectivity — no significant changes in ACTH, cortisol, prolactin, or TSH at effective GH-releasing doses. Clinical trials for mail-surgical ileus (bowel recovery) used IV administration successfully. Sleep-specific research shows that GH secretagogues administered before bedtime increase slow-wave sleep duration by 20-50% in both young and older adults. Ipamorelin's clean side-effect profile makes it the preferred GH peptide for sleep optimization among researchers and clinicians.
Frequently Asked Questions
Common questions about Ipamorelin
UK-Specific Information
Exclusive data points and guidance for UK residents using Ipamorelin
UK Lab Testing
US Lab Testing
Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.